reversed-phase HPLC is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-03-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Retatrutide is an investigational peptide developed by a pharmaceutical company as a multi-receptor agonist for treating obesity and type 2 diabetes. The compound emerged from research into gut-hormone analogues that act on several receptors simultaneously rather than on a single target. Early preclinical work examined how combined activity at three distinct receptors might produce greater metabolic effects than single-receptor compounds. Published phase 2 results have described substantial reductions in body weight among participants, although the compound remains unapproved in most jurisdictions as of the mid-2020s.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
Laboratory handling follows the conventions used for other synthetic peptides. Lyophilized material is weighed and dissolved in an aqueous diluent, typically sterile water or bacteriostatic water, using gentle swirling rather than vigorous shaking, because foaming stresses the chain. Solutions are prepared under clean conditions and, where sterility matters, passed through a suitable filter. Working portions are kept small so that stock material is not repeatedly warmed and cooled, a practice that limits both aggregation and gradual loss of activity.
Stability depends strongly on physical state. Dry powder is comparatively robust when held at -20 °C or below, desiccated and shielded from light; under those conditions degradation is slow and measured over years. Once dissolved, the peptide becomes far more vulnerable: backbone hydrolysis, oxidation of susceptible residues and aggregation all proceed faster in solution, and the rates climb with temperature and with pH far from neutral. Refrigerated storage at 2–8 °C extends usable life for short periods, and repeated freeze–thaw cycles are best avoided.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Contains non-natural residues |
| Receptor targets | GLP-1, GIP, glucagon | Triple agonist profile |
| Route of administration | Subcutaneous injection | In clinical trial settings |
| Development status | Investigational | Not approved in major markets |
| Approximate molecular mass | About 4.7 kDa | Peptide-scale molecule |
供应环节涉及来源核实与文件审核两类工作。分析证书、批次记录以及第三方检测报告构成常见的可追溯材料。来源不清的样品很难确认身份与纯度，因此核实步骤在实际操作中具有明确意义。缺少方法细节的报告通常无法复核。
多肽类化合物的表征通常依赖色谱与质谱联用技术。反相高效液相色谱用于评估纯度与有关物质，质谱用于确认分子量，肽图分析通过酶解碎片比对验证一级结构。这些手段组合使用，可以把目标产物与降解产物或类似物区分开来。单一方法往往不足以完成完整确认。
Identification and purity assessment typically rely on reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Mass measurement confirms the expected molecular mass and can reveal truncations or modifications. Peptide mapping and sequencing techniques provide sequence-level confirmation when needed. Because related peptide impurities can behave similarly in a single method, orthogonal techniques are usually combined. Reported purity values depend heavily on the method used and should be interpreted with that in mind.
Dissolution behavior depends on the amino acid sequence, the counterion content, and the buffer chosen. Many peptides disperse readily in water or mild aqueous buffers, while others require a small amount of organic co-solvent or a change in pH. Adsorption to plastic and glass surfaces can reduce the concentration of a solution over time, particularly at low concentrations. Filtration before analysis removes particulates, and aliquoting limits repeated freeze-thaw cycles that stress the material.
The Bain de Soleil brand transitioned from Procter & Gamble (P&G) to Pfizer in August 1995. The product recipes and certain pieces of manufacturing and packaging equipment were relocated from Hatboro, PA (P&G) to Pfizer Consumer Healthcare Group in Parsippany, New Jersey around October 1995. From November 1995 to 1999, the product was manufactured and packaged at the Pfizer CHCG 100 Jefferson Road, Parsippany, NJ site. During this time, the brand saw the largest portfolio enlargement, including self-tanning (sunless) and after-sun products. These products were all formulated at the same Pfizer site at the 400 Webro Road laboratories. Between 1995 and 1999, the following Bain de Soleil products were marketed:
President Aoun, who assumed office in January 2025, aims to consolidate all arms under state control and plans to initiate talks with Hezbollah amid growing domestic and international pressure. The 2024 conflict with Israel significantly weakened Hezbollah, resulting in the loss of key leaders and a substantial portion of its arsenal. A U.S.-brokered ceasefire requires the Lebanese army to dismantle unauthorized military facilities, particularly south of the Litani River. While Hezbollah may consider transferring its heaviest weapons to the army, it insists that Israel must first meet its demands. Discussions are underway among various Lebanese political leaders and institutions, including Parliament Speaker Nabih Berri and the Maronite Church. The U.S. has reiterated its call for Hezbollah's disarmament, and several Lebanese ministers advocate for a disarmament timetable based on post-civil war precedents. Hezbollah maintains it no longer has an armed presence south of the Litani, though Israel disputes this, accusing the group of retaining military infrastructure. Hezbollah emphasized diplomacy but warned of other options if Israel does not comply. In July 2025, it was reported that Hezbollah had lost 10,000 fighters during the war, and that its military capabilities had also deteriorated significantly. Israel's efforts against Hezbollah have focused on its military assets as well as its finances, with an emphasis on the estimated $700 million directed from Iran each year through intermediaries that accounted for most of Hezbollah's annual operating budget.
In 2010, it was estimated that about 250,000 t of nuclear HLW were stored globally. This does not include amounts that have escaped into the environment from accidents or tests. Japan is estimated to hold 17,000 t of HLW in storage in 2015. As of 2019, the United States has over 90,000 t of HLW. HLW have been shipped to other countries to be stored or reprocessed and, in some cases, shipped back as active fuel. The ongoing controversy over high-level radioactive waste disposal is a major constraint on nuclear power global expansion. Most scientists agree that the main proposed long-term solution is deep geological burial, either in a mine or a deep borehole. As of 2019, no dedicated civilian high-level nuclear waste site is operational as small amounts of HLW did not justify the investment in the past. Finland is in the advanced stage of the construction of the Onkalo spent nuclear fuel repository, which is planned to open in 2025 at 400–450 m depth. France is in the planning phase for a 500 m deep Cigeo facility in Bure. Sweden is planning a site in Forsmark. Canada plans a 680 m deep facility near Lake Huron in Ontario. The Republic of Korea plans to open a site around 2028. The site in Sweden enjoys 80% support from local residents as of 2020. The Morris Operation in Grundy County, Illinois, is currently the only de facto high-level radioactive waste storage site in the United States.
Sources: en.wikipedia.org
=== Capillary rise of liquid between two glass plates === The product of layer thickness (d) and elevation height (h) is constant (d·h = constant), the two quantities are inversely proportional. The surface of the liquid between the planes is hyperbola.
== Sources == The burning of fossil fuels for energy produces 36.8 billion tonnes of CO2 per year as of 2023. Nearly all of this goes into the atmosphere, where approximately half is subsequently absorbed into natural carbon sinks. Less than 1% of CO2 produced annually is put to commercial use.
Gestational diabetes is a condition in which an individual without diabetes develops high blood sugar levels during pregnancy. Gestational diabetes generally results in few symptoms. Obesity increases the rate of pre-eclampsia, cesarean sections, and embryo macrosomia, as well as gestational diabetes. Babies born to individuals with poorly treated gestational diabetes are at increased risk of macrosomia, of having hypoglycemia after birth, and of jaundice. If untreated, diabetes can also result in stillbirth. Long term, children are at higher risk of being overweight and of developing type 2 diabetes. Gestational diabetes can occur during pregnancy because of insulin resistance or reduced production of insulin. Risk factors include being overweight, previously having gestational diabetes, a family history of type 2 diabetes, and having polycystic ovarian syndrome. Diagnosis is by blood tests. For those at normal risk, screening is recommended between 24 and 28 weeks' gestation. For those at high risk, testing may occur at the first prenatal visit. Maintaining a healthy weight and exercising before pregnancy assists in prevention. Gestational diabetes is treated with a healthy eating plan, exercise, medication (such as metformin), and sometimes insulin injections. Most people manage blood sugar with diet and exercise. Blood sugar testing among those affected is often recommended four times daily. Breastfeeding is recommended as soon as possible after birth. Gestational diabetes affects 3–9% of pregnancies, depending on the population studied.
Sources: en.wikipedia.org
It is designed as a triple agonist acting on the GLP-1, GIP, and glucagon receptors. This combination is intended to influence appetite, insulin secretion, and energy expenditure. Single-receptor and dual-receptor compounds act on a narrower set of targets.
No. It remains investigational, and phase 3 results have not been fully published or reviewed by regulators. Official approval status should be confirmed through regulatory agencies rather than secondary sources.
The added glucagon receptor activity is the main difference in its mechanism. Whether that addition produces meaningful benefits in clinical outcomes is still being studied. Comparisons between compounds rest largely on indirect rather than head-to-head trial data.
Purity is normally given as a percentage from reversed-phase HPLC, calculated as the main peak area relative to total peak area. Research-grade material is commonly specified at 95 per cent or higher, with tighter specifications available. The number is method-dependent and should be read alongside the chromatogram.